The medicinal products database of the Federal Agency for Medicines and Health Products (FAMHP) contains all medicines for human and veterinary use that have a valid marketing authorisation, registration, parallel import authorisation or a temporary use authorisation in Belgium. The database also includes, in a separate section, the medicines whose authorisation have been suspended or withdrawn since 1 January 2019.
The medicinal products database is subdivided into medicines for human and veterinary use.
The database contains links to relevant documents such as the patient information leaflet, the Summary of Product Characteristics (SPC), Risk Minimisation Activities (RMA) and Direct Healthcare Professional Communication (DHPC).
All this information is important in order to ensure that medicines are prescribed, dispensed and used safely and appropriately.